Howe & Rusling Inc Curis Inc Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $63 - $218	90 Added 180.0%	140 $0
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $372 - $813	50 New	50 $0
Q1 2021 May 13, 2021	SELL	$8.78 - $12.8 $263 - $384	-30 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$1.08 - $8.2 $32 - $245	30 New	30 $0

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.